Team:Wageningen UR/Parts

From 2013.igem.org

(Difference between revisions)
(Prototype team page)
(→Ownership)
 
(31 intermediate revisions not shown)
Line 1: Line 1:
-
<!-- *** What falls between these lines is the Alert Box! You can remove it from your pages once you have read and understood the alert *** -->
+
<!--- Header Template --->
-
 
+
{{:Team:Wageningen_UR/Templates/Page Header}}
 +
<!--- Navigation Template --->
 +
{{:Team:Wageningen_UR/Templates/Navigation}}
<html>
<html>
-
<div id="box" style="width: 700px; margin-left: 137px; padding: 5px; border: 3px solid #000; background-color: #fe2b33;">
+
<script type="text/javascript">
-
<div id="template" style="text-align: center; font-weight: bold; font-size: large; color: #f6f6f6; padding: 5px;">
+
function tab(tab) {
-
This is a template page. READ THESE INSTRUCTIONS.
+
document.getElementById('tab1').style.display = 'none';
 +
document.getElementById('tab2').style.display = 'none';
 +
document.getElementById('li_tab1').setAttribute("class", "");
 +
document.getElementById('li_tab2').setAttribute("class", "");
 +
document.getElementById(tab).style.display = 'block';
 +
document.getElementById('li_'+tab).setAttribute("class", "active");
 +
}
 +
$(document).ready(function(){
 +
    $(window).load(function(){
 +
        $('#groupparts .pgrouptable tbody tr:nth-child(5)').html('');
 +
    });
 +
});
 +
</script>
 +
<div class="bricksheader">
 +
<img src="https://static.igem.org/mediawiki/2013/8/80/Bricksheader.jpg">
 +
<div class="content">
 +
    <h1>Biobricks</h1>
 +
    <p>The registry of Standard Parts plays a crucial role in the open access iGEM community. This means that all constructed parts are made available to everyone. Before we sent in our biobricks, some of them suddenly contained one or more mutations, thereby undoing the characterization we performed for these bricks. Although we now characterized that the bricks containing some mutations also still work properly, i.e. the pkiA promoter brick, we believe in thorough and proper registering of parts. We will therefore send these bricks after the deadline for handing in biobricks! Sharing is caring!<br/><br/></p>
</div>
</div>
-
<div id="instructions" style="text-align: center; font-weight: normal; font-size: small; color: #f6f6f6; padding: 5px;">
 
-
You are provided with this team page template with which to start the iGEM season.  You may choose to personalize it to fit your team but keep the same "look." Or you may choose to take your team wiki to a different level and design your own wiki.  You can find some examples <a href="https://2008.igem.org/Help:Template/Examples">HERE</a>.
 
</div>
</div>
-
<div id="warning" style="text-align: center; font-weight: bold; font-size: small; color: #f6f6f6; padding: 5px;">
+
<div id="wrapper">
-
You <strong>MUST</strong> have all of the pages listed in the menu below with the names specified.  PLEASE keep all of your pages within your teams namespace. 
+
<div id="bricktabs">
 +
<ul>
 +
<li id="li_tab1" onclick="tab('tab1')" class="active"><a>Our biobricks</a></li>
 +
<li id="li_tab2" onclick="tab('tab2')"><a>Improved biobricks</a></li>
 +
</ul>
</div>
</div>
 +
<div id="brick_content_area">
 +
 +
<div id="tab1">
 +
</html>
 +
<groupparts>iGEM013 Wageningen_UR</groupparts>
 +
<html>
 +
<div id="pagewrapper">
 +
</html>
 +
==Ownership==
 +
<html>
 +
<p><b>“Share.. not scare!”</b></p>
 +
<p>During a research project some materials that are not available in-house are sometimes requested from other parties. A material transfer agreement (MTA) is made to formalize the exchange of biological parts like cell-lines, plasmids and reagents and protect the rights of all the parties involved. There is specific expectations regarding compensation for the help provided by the distributor when transferring material. The negotiations and demands in an MTA can stifle the spreading of new discoveries, slow down transfer of technology and limit future avenues of research. Some of the obligations include reach‐through provisions, royalties and fees, publication restrictions, and even restrictions in material distribution to non profit organizations, like the iGEM parts registry.</p>
 +
<p>According to Mirowsky and Van Horn, an MTA is a special signal that commercial firms award to academics when they are unenthusiastic about the request to collaborate[<a href="#ref1">1</a>]. Furthermore, Streitz and Bennett argue that when companies are material suppliers, academic scientists might be tightly restricted in their academic freedom because MTAs may require researchers to assign or license intellectual property rights to discoveries made in the course of using the material, prohibit sharing research material with other researchers or forbid sending it to other institutions[<a href="ref2">2</a>.</p>
 +
<p>During our research we implemented ATP and pH bio-sensors in Aspergillus niger which were obtained after signing MTAs with different research groups. These contracts currently prevent us from depositing invaluable parts or bio-bricks that contain this DNA, to the iGEM parts registry. This is a pity because these parts increase the repetoire of tools that are currently at the disposal of the open iGEM community. Even the iGEM policy of Get & Give (& Share) was not sufficient to get the permission to submit these parts.</p>
 +
<p>We believe opennes and free sharing is very important for broader dissemination of new discoveries to pervade into all research spaces. The use of copyleft is suggested as an alternative. Copyleft type licenses are a novel use of existing copyright law to ensure a work remains freely available. The idea is to sign an agreement or contract between the exchanging parties such that the recipient can freely modify the provided material but in-turn has to freely share the derivatives with other groups. Because in the end sharing is caring!</p>
</div>
</div>
 +
<div id="pagewrapper">
</html>
</html>
-
<!-- *** End of the alert box *** -->
+
==References==
 +
<html>
 +
<p id="ref1"><span class="ref">1.</span>Mirowsky and Van Horn, <i>op. cit.</i></p>
 +
<p id="ref2"><span class="ref">2.</span>W. Streitz and A. Bennett, ‘Material transfer agreements: a university perspective’, <i>Plant Physiology</i>, 133, 2003, pp. 10–3.</p>
 +
</div>
 +
</div>
-
{| style="color:#1b2c8a;background-color:#0c6;" cellpadding="3" cellspacing="1" border="1" bordercolor="#fff" width="62%" align="center"
+
<div id="tab2">
-
!align="center"|[[Team:Wageningen_UR|Home]]
+
<p></p>
-
!align="center"|[[Team:Wageningen_UR/Team|Team]]
+
<div id="groupparts" style="min-height:100px;width:700px;">
-
!align="center"|[https://igem.org/Team.cgi?year=2013&team_name=Wageningen_UR Official Team Profile]
+
<table class=" pgrouptable tablesorter" style="width: 100%;" cellpadding="0" cellspacing="0">
-
!align="center"|[[Team:Wageningen_UR/Project|Project]]
+
<thead>
-
!align="center"|[[Team:Wageningen_UR/Parts|Parts Submitted to the Registry]]
+
<tr><th style="width:8px" class="header"></th><th style="width:8px" class="header"></th><th style="width:8px" class="header"></th><th style="width: 87px;" class="header">Name</th><th style="width: 80px" colspan="" class="header">Type</th><th style="width: auto;" colspan="" class="header">Description</th><th style="width: 150px" colspan="" class="header">Designer</th><th style="width: 50px" colspan="" class="header">Length</th>
-
!align="center"|[[Team:Wageningen_UR/Modeling|Modeling]]
+
</tr></thead><tbody>
-
!align="center"|[[Team:Wageningen_UR/Notebook|Notebook]]
+
<tr>
-
!align="center"|[[Team:Wageningen_UR/Safety|Safety]]
+
<td class="status_cell  "></td><td class="status_cell cell_white">&nbsp;</td><td class="status_cell cell_white">&nbsp;</td><td><a class="noul_link part_link" href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1023005">BBa_K1023005</a></td><td>Coding</td><td>eforRed</td><td width="100px">Michiel Karrenbelt</td><td align="right">687</td>
-
!align="center"|[[Team:Wageningen_UR/Attributions|Attributions]]
+
</tr>
-
|}
+
</tbody>
 +
</table>
 +
</div>
 +
</div>
-
 
+
</div>
-
 
+
</html>
-
An important aspect of the iGEM competition is the use and creation of standard  biological parts. Each team will make new parts during iGEM and will place them in the [http://partsregistry.org Registry of Standard Biological Parts]. The iGEM software provides an easy way to present the parts your team has created . The "groupparts" tag will generate a table with all of the parts that your team adds to your team sandbox.  Note that if you want to document a part you need to document it on the [http://partsregistry.org Registry], not on your team wiki.
+
<!--- Footer Template --->
-
 
+
{{:Team:Wageningen_UR/Templates/Page Footer}}
-
Remember that the goal of proper part documentation is to describe and define a part such that it can be used without a need to refer to the primary literature. The next iGEM team should be able to read your documentation and be able to use the part successfully. Also, you should provide proper references to acknowledge previous authors and to provide for  users who wish to know more.
+
-
 
+
-
 
+
-
<groupparts>iGEM013 Wageningen_UR</groupparts>
+

Latest revision as of 03:32, 5 October 2013

Biobricks

The registry of Standard Parts plays a crucial role in the open access iGEM community. This means that all constructed parts are made available to everyone. Before we sent in our biobricks, some of them suddenly contained one or more mutations, thereby undoing the characterization we performed for these bricks. Although we now characterized that the bricks containing some mutations also still work properly, i.e. the pkiA promoter brick, we believe in thorough and proper registering of parts. We will therefore send these bricks after the deadline for handing in biobricks! Sharing is caring!

<groupparts>iGEM013 Wageningen_UR</groupparts>

Ownership

“Share.. not scare!”

During a research project some materials that are not available in-house are sometimes requested from other parties. A material transfer agreement (MTA) is made to formalize the exchange of biological parts like cell-lines, plasmids and reagents and protect the rights of all the parties involved. There is specific expectations regarding compensation for the help provided by the distributor when transferring material. The negotiations and demands in an MTA can stifle the spreading of new discoveries, slow down transfer of technology and limit future avenues of research. Some of the obligations include reach‐through provisions, royalties and fees, publication restrictions, and even restrictions in material distribution to non profit organizations, like the iGEM parts registry.

According to Mirowsky and Van Horn, an MTA is a special signal that commercial firms award to academics when they are unenthusiastic about the request to collaborate[1]. Furthermore, Streitz and Bennett argue that when companies are material suppliers, academic scientists might be tightly restricted in their academic freedom because MTAs may require researchers to assign or license intellectual property rights to discoveries made in the course of using the material, prohibit sharing research material with other researchers or forbid sending it to other institutions[2.

During our research we implemented ATP and pH bio-sensors in Aspergillus niger which were obtained after signing MTAs with different research groups. These contracts currently prevent us from depositing invaluable parts or bio-bricks that contain this DNA, to the iGEM parts registry. This is a pity because these parts increase the repetoire of tools that are currently at the disposal of the open iGEM community. Even the iGEM policy of Get & Give (& Share) was not sufficient to get the permission to submit these parts.

We believe opennes and free sharing is very important for broader dissemination of new discoveries to pervade into all research spaces. The use of copyleft is suggested as an alternative. Copyleft type licenses are a novel use of existing copyright law to ensure a work remains freely available. The idea is to sign an agreement or contract between the exchanging parties such that the recipient can freely modify the provided material but in-turn has to freely share the derivatives with other groups. Because in the end sharing is caring!

References

1.Mirowsky and Van Horn, op. cit.

2.W. Streitz and A. Bennett, ‘Material transfer agreements: a university perspective’, Plant Physiology, 133, 2003, pp. 10–3.

NameTypeDescriptionDesignerLength
  BBa_K1023005CodingeforRedMichiel Karrenbelt687

Retrieved from "http://2013.igem.org/Team:Wageningen_UR/Parts"